Anupam Rasayan India Ltd NSE:ANURAS:
DENIES PLANS TO BUY STAKE IN BLISS GVS PHARMA
Anupam Rasayan India Denies Plans To Buy Stake In Bliss GVS Pharma
Earlier from Bliss Gvs Pharma
- BLISSGVS: Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared
- Bliss GVS Pharma board approves appointment of S.N. Kamath as Managing Director
- Bliss GVS Pharma Incorporates Theralife Pharma In Kenya
- Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees